臨床検査の世界市場:種類別(CBC、HGB / HCT、BMP、BUNクレアチニン、電解質テスト、HbA1c、CMP、肝臓パネル、腎臓パネル、脂質パネル)、最終用途別

◆英語タイトル:Clinical Laboratory Tests Market Size, Share & Trends Analysis Report By Type (CBC, HGB/HCT, BMP, BUN Creatinine, Electrolyte Testing, HbA1c, CMP, Liver Panel, Renal Panel, Lipid Panel), By End Use, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20MY039
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年2月24日
◆ページ数:100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥624,750見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥729,750見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥939,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、臨床検査の世界市場について調査・分析し、調査手法、エグゼクティブサマリー、市場要因・動向・範囲、競争分析、種類別(CBC、HGB / HCT、BMP、BUNクレアチニン、電解質テスト、HbA1c、CMP、肝臓パネル、腎臓パネル、脂質パネル)分析、最終用途別(セントラル研究所、プライマリークリニック)分析、地域別分析、企業概要などの構成でお届けいたします。
・調査手法
・エグゼクティブサマリー
・市場要因・動向・範囲
・競争分析
・臨床検査の世界市場:種類別(CBC、HGB / HCT、BMP、BUNクレアチニン、電解質テスト、HbA1c、CMP、肝臓パネル、腎臓パネル、脂質パネル)
・臨床検査の世界市場:最終用途別(セントラル研究所、プライマリークリニック)
・臨床検査の世界市場:地域別
・企業概要
【レポートの概要】

The global clinical laboratory tests market size is expected to reach USD 304.9 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 7.1% over the forecast period. Introduction of new solutions for minimizing errors and maximizing efficiency is anticipated to boost the overall market growth.

Presence of favorable reimbursement plans for laboratory tests is anticipated to positively influence the global market. According to an article published in the American Clinical Laboratory Association (ACLA), these tests are reimbursed by Medicare payees either under the Physician Fee Schedule or Clinical Laboratory Fee Schedule based on the nature of service.

According to an article published in Forbes, in 2018, the new clinical lab fee schedule reduced their overall payments by 10% as compared to 2017 for tests that represent nearly two-thirds of Medicare’s outlays for laboratory tests.

In addition, growing demand for early detection of several diseases is anticipated to drive the clinical laboratory tests market over the forecast period. For instance, biochips are used for preparing thousands of DNA, RNA, or protein samples that can be processed on a single chip at the same time. According to an article published in the American Clinical Laboratory Association, more than 7 billion clinical laboratory examinations are performed each year in U.S.

Presence of major players such as QIAGEN, Laboratory Corporation of America Holdings, Siemens Healthcare GmbH, Quest Diagnostics Incorporated, and Abbott is expected to fuel the market growth. These companies are involved in undertaking initiatives such as product development, strategic collaborations, and regional expansion.

In November 2019, QIAGEN entered into a strategic agreement with Laboratory Corporation of America Holdings to extend its existing QIAGEN Clinical Insights license. Moreover, in August 2018, QIAGEN collaborated with SRL, Inc., Japan’s largest clinical testing lab company, to prepare for the introduction of novel companion diagnostic tests along with new drug approvals.

Further key findings from the report suggest:

• In 2019, basic metabolic panel dominated the type segment owing to the increasing prevalence of lifestyle-induced diseases

• Lipid panel is projected to register a CAGR of 8.0% over the forecast period owing to rising incidences of cardiovascular disorders globally

• In 2019, hepatitis dominated the liver panel segment whereas liver cirrhosis is estimated to be the fastest-growing sub-segment over the forecast period

• Central laboratories dominated the overall market in 2019 owing to the expansion of key laboratories such as Q2 Solutions and Pharmaceutical Product Development, LLC

• Primary clinics is anticipated to register a significant CAGR of 7.6% from 2020 to 2027 owing to advancements such as portable and rapid diagnostic tests

• North America dominated the global market in 2019 owing to the increasing geriatric population and high disease prevalence

• Asia Pacific is projected to be the fastest-growing market over the forecast period owing to improving healthcare infrastructure.

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Market definition
1.3. Information procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources & third-party perspectives
1.3.4. Primary research
1.4. Information analysis
1.4.1. Data analysis models
1.5. Market formulation & data visualization
1.6. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Global Clinical Laboratory Tests Market Variables, Trends & Scope
3.1. Clinical Laboratory Tests Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Cost Structure Analysis
3.4. Reimbursement Framework
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.1.1. Rising geriatric population base
3.5.1.2. Growing prevalence of target diseases
3.5.1.3. Introduction of innovative solutions
3.5.1.4. Rising demand for early disease detection
3.5.2. Market restraint analysis
3.5.2.1. Presence of ambiguous regulatory framework
3.6. Clinical Laboratory Tests Market Analysis Tools
3.6.1. Industry analysis – Porter’s
3.6.1.1. Supplier Power: Moderate due to large number of diagnostic test manufacturers
3.6.1.2. Buyer Power: Moderate due to presence of players entering into long-term contract
3.6.1.3. Substitution Threat: Low due to no/less external substitutes
3.6.1.4. Threat from new entrants: Moderate due to brand recognition of the existing players
3.6.1.5. Competitive rivalry: High due to increasing mergers & acquisitions by major players
3.7. PESTEL Analysis
3.7.1. Political landscape
3.7.2. Environmental landscape
3.7.3. Social landscape
3.7.4. Technology landscape
3.7.5. Legal landscape
3.8. Major Deals & Strategic Alliances Analysis
3.8.1. Joint ventures
3.8.2. Mergers & acquisitions
3.8.3. Licensing & partnership
3.8.4. Technology collaborations
3.8.5. Strategic divestments
Chapter 4. Clinical Laboratory Tests Market – Competitive Analysis
4.1. Recent developments & impact analysis, by key market participants
4.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
4.3. Public Companies
4.3.1. Company market position analysis
4.3.2. Company market share/ranking, by region
4.3.3. Competitive dashboard analysis
4.3.4. Market differentiators
4.3.5. Synergy Analysis: Major Deals & Strategic Alliances
4.4. Private Companies
4.4.1. List of key emerging companies
4.4.2. Regional network map
4.4.3. Company market position analysis
Chapter 5. Clinical Laboratory Tests Market: Type Estimates & Trend Analysis
5.1. Definitions & Scope
5.2. Type market share analysis, 2019 & 2027
5.3. Type Dashboard
5.4. Global Clinical Laboratory Test Market, by Type, 2016 to 2027
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following,
5.5.1. Complete blood count
5.5.2. HGB/HCT testing
5.5.3. Basic metabolic panel testing
5.5.4. BUN creatinine testing
5.5.5. Electrolytes testing
5.5.6. HbA1c testing
5.5.7. Comprehensive metabolic panel testing
5.5.8. Liver panel testing
5.5.8.1. Hepatitis
5.5.8.2. Bile duct obstruction
5.5.8.3. Liver Cirrhosis
5.5.8.4. Liver Cancer
5.5.8.5. Bone disease
5.5.8.6. Autoimmune disorders
5.5.8.7. Others
5.5.9. Renal panel testing
5.5.10. Lipid panel testing
Chapter 6. Clinical Laboratory Tests Market: End-use Estimates & Trend Analysis
6.1. Definitions & Scope
6.2. End-use market share analysis, 2019 & 2027
6.3. End-use Dashboard
6.4. Global Clinical Laboratory Test Market, by End-use, 2016 to 2027
6.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following,
6.5.1. Central Laboratories
6.5.1.1. Complete blood count
6.5.1.2. HGB/HCT testing
6.5.1.3. Basic metabolic panel testing
6.5.1.4. BUN creatinine testing
6.5.1.5. Electrolytes testing
6.5.1.6. HbA1c testing
6.5.1.7. Comprehensive metabolic panel testing
6.5.1.8. Liver panel testing
6.5.1.9. Renal panel testing
6.5.1.10. Lipid panel testing
6.5.2. Primary Clinics
6.5.2.1. Complete blood count
6.5.2.2. HGB/HCT testing
6.5.2.3. Basic metabolic panel testing
6.5.2.4. BUN creatinine testing
6.5.2.5. Electrolytes testing
6.5.2.6. HbA1c testing
6.5.2.7. Comprehensive metabolic panel testing
6.5.2.8. Liver panel testing
6.5.2.9. Renal panel testing
6.5.2.10. Lipid panel testing
Chapter 7. Clinical Laboratory Tests Market: Regional Estimates & Trend Analysis, by Type, End-Use and End-Use by Type
7.1. Regional Market Snapshot
7.2. Regional Market Share and Leading Players, 2019
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
7.3.1. North America
7.3.2. Europe
7.3.3. Asia Pacific
7.3.4. Latin America
7.3.5. Middle East & Africa
7.4. Market Size, & Forecasts, and Trend Analysis, 2019 to 2027
7.4.1. North America
7.4.1.1. U.S.
7.4.1.2. Canada
7.4.2. Europe
7.4.2.1. U.K.
7.4.2.2. Germany
7.4.2.3. Spain
7.4.2.4. France
7.4.2.5. Italy
7.4.2.6. Russia
7.4.3. Asia Pacific
7.4.3.1. China
7.4.3.2. Japan
7.4.3.3. India
7.4.3.4. South Korea
7.4.3.5. Singapore
7.4.3.6. Australia
7.4.4. South America
7.4.4.1. Brazil
7.4.4.2. Mexico
7.4.4.3. Argentina
7.4.5. Middle East Africa
7.4.5.1. South Africa
7.4.5.2. Saudi Arabia
7.4.5.3. UAE
Chapter 8. Company Profiles
8.1. Strategic Framework
8.1.1. Abbott
8.1.1.1. Company overview
8.1.1.2. Financial framework
8.1.1.3. Product benchmarking
8.1.1.4. Strategic initiatives
8.1.2. ARUP Laboratories
8.1.2.1. Company overview
8.1.2.2. Financial framework
8.1.2.3. Product benchmarking
8.1.2.4. Strategic initiatives
8.1.3. OPKO Health, Inc.
8.1.3.1. Company overview
8.1.3.2. Financial framework
8.1.3.3. Product benchmarking
8.1.3.4. Strategic initiatives
8.1.4. Bioscientia Institut für Medizinische Diagnostik GmbH
8.1.4.1. Company overview
8.1.4.2. Financial framework
8.1.4.3. Product benchmarking
8.1.4.4. Strategic initiatives
8.1.5. Charles River
8.1.5.1. Company overview
8.1.5.2. Financial framework
8.1.5.3. Product benchmarking
8.1.5.4. Strategic initiatives
8.1.6. Neogenomics Laboratories, Inc. (Clarient, Inc.)
8.1.6.1. Company overview
8.1.6.2. Financial framework
8.1.6.3. Product benchmarking
8.1.6.4. Strategic initiatives
8.1.7. Genoptix, Inc.
8.1.7.1. Company overview
8.1.7.2. Financial framework
8.1.7.3. Product benchmarking
8.1.7.4. Strategic initiatives
8.1.8. Healthscope
8.1.8.1. Company overview
8.1.8.2. Financial framework
8.1.8.3. Product benchmarking
8.1.8.4. Strategic initiatives
8.1.9. Labco S.A
8.1.9.1. Company overview
8.1.9.2. Financial framework
8.1.9.3. Product benchmarking
8.1.9.4. Strategic initiatives
8.1.10. Laboratory Corporation of America Holdings (LabCorp)
8.1.10.1. Company overview
8.1.10.2. Financial framework
8.1.10.3. Product benchmarking
8.1.10.4. Strategic initiatives
8.1.11. QIAGEN
8.1.11.1. Company overview
8.1.11.2. Financial framework
8.1.11.3. Product benchmarking
8.1.11.4. Strategic initiatives
8.1.12. Quest Diagnostics
8.1.12.1. Company overview
8.1.12.2. Financial framework
8.1.12.3. Product benchmarking
8.1.12.4. Strategic initiatives
8.1.13. Siemens Healthcare Private Limited
8.1.13.1. Company overview
8.1.13.2. Financial framework
8.1.13.3. Product benchmarking
8.1.13.4. Strategic initiatives
8.1.14. Sonic Healthcare
8.1.14.1. Company overview
8.1.14.2. Financial framework
8.1.14.3. Product benchmarking
8.1.14.4. Strategic initiatives
8.1.15. Fresenius Medical Care Holdings, Inc.
8.1.15.1. Company overview
8.1.15.2. Financial framework
8.1.15.3. Product benchmarking
8.1.15.4. Strategic initiatives
8.1.16. Merck KgaA
8.1.16.1. Company overview
8.1.16.2. Financial framework
8.1.16.3. Product benchmarking
8.1.16.4. Strategic initiatives
8.1.17. Tulip Diagnostics
8.1.17.1. Company overview
8.1.17.2. Financial framework
8.1.17.3. Product benchmarking
8.1.17.4. Strategic initiatives
8.1.18. Biosino Bio-technology and Science Inc.
8.1.18.1. Company overview
8.1.18.2. Financial framework
8.1.18.3. Product benchmarking
8.1.18.4. Strategic initiatives

List of Tables

TABLE 1 List of secondary sources
TABLE 2 North America corporate wellness market, by country, 2016 - 2027 (USD Million)
TABLE 3 North America corporate wellness market, by service, 2016 - 2027 (USD Million)
TABLE 4 North America corporate wellness market, by end use, 2016 - 2027 (USD Million)
TABLE 5 North America corporate wellness market, by category, 2016 - 2027 (USD Million)
TABLE 6 North America corporate wellness market, by type, 2016 - 2027 (USD Million)
TABLE 7 North America corporate wellness market, by delivery model, 2016 - 2027 (USD Million)
TABLE 8 U.S. corporate wellness market, by service, 2016 - 2027 (USD Million)
TABLE 9 U.S. corporate wellness market, by end use, 2016 - 2027 (USD Million)
TABLE 10 U.S. corporate wellness market, by category, 2016 - 2027 (USD Million)
TABLE 11 U.S. corporate wellness market, by type, 2016 - 2027 (USD Million)
TABLE 12 U.S. corporate wellness market, by delivery model, 2016 - 2027 (USD Million)
TABLE 13 Canada corporate wellness market, by service, 2016 - 2027 (USD Million)
TABLE 14 Canada corporate wellness market, by end use, 2016 - 2027 (USD Million)
TABLE 15 Canada corporate wellness market, by category, 2016 - 2027 (USD Million)
TABLE 16 Canada corporate wellness market, by type, 2016 - 2027 (USD Million)
TABLE 17 Canada corporate wellness market, by delivery model, 2016 - 2027 (USD Million)
TABLE 18 Europe corporate wellness market, by country, 2016 - 2027 (USD Million)
TABLE 19 Europe corporate wellness market, by service, 2016 - 2027 (USD Million)
TABLE 20 Europe corporate wellness market, by end use, 2016 - 2027 (USD Million)
TABLE 21 Europe corporate wellness market, by category, 2016 - 2027 (USD Million)
TABLE 22 Europe corporate wellness market, by type, 2016 - 2027 (USD Million)
TABLE 23 Europe corporate wellness market, by delivery model, 2016 - 2027 (USD Million)
TABLE 24 U.K. corporate wellness market, by service, 2016 - 2027 (USD Million)
TABLE 25 U.K. corporate wellness market, by end use, 2016 - 2027 (USD Million)
TABLE 26 U.K. corporate wellness market, by category, 2016 - 2027 (USD Million)
TABLE 27 U.K. corporate wellness market, by type, 2016 - 2027 (USD Million)
TABLE 28 U.K. corporate wellness market, by delivery model, 2016 - 2027 (USD Million)
TABLE 29 Germany corporate wellness market, by service, 2016 - 2027 (USD Million)
TABLE 30 Germany corporate wellness market, by end use, 2016 - 2027 (USD Million)
TABLE 31 Germany corporate wellness market, by category, 2016 - 2027 (USD Million)
TABLE 32 Germany corporate wellness market, by type, 2016 - 2027 (USD Million)
TABLE 33 Germany corporate wellness market, by delivery model, 2016 - 2027 (USD Million)
TABLE 34 France corporate wellness market, by service, 2016 - 2027 (USD Million)
TABLE 35 France corporate wellness market, by end use, 2016 - 2027 (USD Million)
TABLE 36 France corporate wellness market, by category, 2016 - 2027 (USD Million)
TABLE 37 France corporate wellness market, by type, 2016 - 2027 (USD Million)
TABLE 38 France corporate wellness market, by delivery model, 2016 - 2027 (USD Million)
TABLE 39 Italy corporate wellness market, by service, 2016 - 2027 (USD Million)
TABLE 40 Italy corporate wellness market, by end use, 2016 - 2027 (USD Million)
TABLE 41 Italy corporate wellness market, by category, 2016 - 2027 (USD Million)
TABLE 42 Italy corporate wellness market, by type, 2016 - 2027 (USD Million)
TABLE 43 Italy corporate wellness market, by delivery model, 2016 - 2027 (USD Million)
TABLE 44 Spain corporate wellness market, by service, 2016 - 2027 (USD Million)
TABLE 45 Spain corporate wellness market, by end use, 2016 - 2027 (USD Million)
TABLE 46 Spain corporate wellness market, by category, 2016 - 2027 (USD Million)
TABLE 47 Spain corporate wellness market, by type, 2016 - 2027 (USD Million)
TABLE 48 Spain corporate wellness market, by delivery model, 2016 - 2027 (USD Million)
TABLE 49 Asia Pacific corporate wellness market, by country, 2016 - 2027 (USD Million)
TABLE 50 Asia Pacific corporate wellness market, by service, 2016 - 2027 (USD Million)
TABLE 51 Asia Pacific corporate wellness market, by end use, 2016 - 2027 (USD Million)
TABLE 52 Asia Pacific corporate wellness market, by category, 2016 - 2027 (USD Million)
TABLE 53 Asia Pacific corporate wellness market, by type, 2016 - 2027 (USD Million)
TABLE 54 Asia Pacific corporate wellness market, by delivery model, 2016 - 2027 (USD Million)
TABLE 55 Japan corporate wellness market, by service, 2016 - 2027 (USD Million)
TABLE 56 Japan corporate wellness market, by end use, 2016 - 2027 (USD Million)
TABLE 57 Japan corporate wellness market, by category, 2016 - 2027 (USD Million)
TABLE 58 Japan corporate wellness market, by type, 2016 - 2027 (USD Million)
TABLE 59 Japan corporate wellness market, by delivery model, 2016 - 2027 (USD Million)
TABLE 60 China corporate wellness market, by service, 2016 - 2027 (USD Million)
TABLE 61 China corporate wellness market, by end use, 2016 - 2027 (USD Million)
TABLE 62 China corporate wellness market, by category, 2016 - 2027 (USD Million)
TABLE 63 China corporate wellness market, by type, 2016 - 2027 (USD Million)
TABLE 64 China corporate wellness market, by delivery model, 2016 - 2027 (USD Million)
TABLE 65 India corporate wellness market, by service, 2016 - 2027 (USD Million)
TABLE 66 India corporate wellness market, by end use, 2016 - 2027 (USD Million)
TABLE 67 India corporate wellness market, by category, 2016 - 2027 (USD Million)
TABLE 68 India corporate wellness market, by type, 2016 - 2027 (USD Million)
TABLE 69 India corporate wellness market, by delivery model, 2016 - 2027 (USD Million)
TABLE 70 Australia corporate wellness market, by service, 2016 - 2027 (USD Million)
TABLE 71 Australia corporate wellness market, by end use, 2016 - 2027 (USD Million)
TABLE 72 Australia corporate wellness market, by category, 2016 - 2027 (USD Million)
TABLE 73 Australia corporate wellness market, by type, 2016 - 2027 (USD Million)
TABLE 74 Australia corporate wellness market, by delivery model, 2016 - 2027 (USD Million)
TABLE 75 Latin America corporate wellness market, by country, 2016 - 2027 (USD Million)
TABLE 76 Latin America corporate wellness market, by service, 2016 - 2027 (USD Million)
TABLE 77 Latin America corporate wellness market, by end use, 2016 - 2027 (USD Million)
TABLE 78 Latin America corporate wellness market, by category, 2016 - 2027 (USD Million)
TABLE 79 Latin America corporate wellness market, by type, 2016 - 2027 (USD Million)
TABLE 80 Latin America corporate wellness market, by delivery model, 2016 - 2027 (USD Million)
TABLE 81 Brazil corporate wellness market, by service, 2016 - 2027 (USD Million)
TABLE 82 Brazil corporate wellness market, by end use, 2016 - 2027 (USD Million)
TABLE 83 Brazil corporate wellness market, by category, 2016 - 2027 (USD Million)
TABLE 84 Brazil corporate wellness market, by type, 2016 - 2027 (USD Million)
TABLE 85 Brazil corporate wellness market, by delivery model, 2016 - 2027 (USD Million)
TABLE 86 Mexico corporate wellness market, by service, 2016 - 2027 (USD Million)
TABLE 87 Mexico corporate wellness market, by end use, 2016 - 2027 (USD Million)
TABLE 88 Mexico corporate wellness market, by category, 2016 - 2027 (USD Million)
TABLE 89 Mexico corporate wellness market, by type, 2016 - 2027 (USD Million)
TABLE 90 Mexico corporate wellness market, by delivery model, 2016 - 2027 (USD Million)
TABLE 91 MEA corporate wellness market, by country, 2016 - 2027 (USD Million)
TABLE 92 MEA corporate wellness market, by service, 2016 - 2027 (USD Million)
TABLE 93 MEA corporate wellness market, by end use, 2016 - 2027 (USD Million)
TABLE 94 MEA corporate wellness market, by category, 2016 - 2027 (USD Million)
TABLE 95 MEA corporate wellness market, by type, 2016 - 2027 (USD Million)
TABLE 96 MEA corporate wellness market, by delivery model, 2016 - 2027 (USD Million)
TABLE 97 South Africa corporate wellness market, by service, 2016 - 2027 (USD Million)
TABLE 98 South Africa corporate wellness market, by end use, 2016 - 2027 (USD Million)
TABLE 99 South Africa corporate wellness market, by category, 2016 - 2027 (USD Million)
TABLE 100 South Africa corporate wellness market, by type, 2016 - 2027 (USD Million)
TABLE 101 South Africa corporate wellness market, by delivery model, 2016 - 2027 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Corporate wellness market outlook, 2019
Fig. 9 Market trends & outlook
Fig. 10 Corporate wellness market segmentation
Fig. 11 Penetration & growth prospect mapping
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Corporate wellness executive plan
Fig. 14 Market restraint relevance analysis (Current & future impact)
Fig. 15 Employee expectations vs. employer offerings
Fig. 16 Corporate wellness service market share analysis, 2019 & 2027
Fig. 17 Corporate wellness service market: Segment dashboard
Fig. 18 Health risk assessment market, 2016 - 2027 (USD Million)
Fig. 19 Fitness market, 2016 - 2027 (USD Million)
Fig. 20 Smoking cessation market, 2016 - 2027 (USD Million)
Fig. 21 Health screening market, 2016 - 2027 (USD Million)
Fig. 22 Nutrition & weight management market, 2016 - 2027 (USD Million)
Fig. 23 Stress management market, 2016 - 2027 (USD Million)
Fig. 24 Others market, 2016 - 2027 (USD Million)
Fig. 25 Corporate wellness end use market share analysis, 2019 & 2027
Fig. 26 Corporate wellness end use market: Segment dashboard
Fig. 27 Small scale organizations market, 2016 - 2027 (USD Million)
Fig. 28 Medium scale organizations market, 2016 - 2027 (USD Million)
Fig. 29 Large scale organizations market, 2016 - 2027 (USD Million)
Fig. 30 Corporate wellness category market share analysis, 2019 & 2027
Fig. 31 Corporate wellness category market: Segment dashboard
Fig. 32 Fitness & nutrition consultants category market, 2016 - 2027 (USD Million)
Fig. 33 Psychological therapists category market, 2016 - 2027 (USD Million)
Fig. 34 Organizations/employers category market, 2016 - 2027 (USD Million)
Fig. 35 Corporate wellness type market share analysis, 2019 & 2027
Fig. 36 Corporate wellness type market: Segment dashboard
Fig. 37 Services market, 2016 - 2027 (USD Million)
Fig. 38 Technology market, 2016 - 2027 (USD Million)
Fig. 39 Corporate wellness delivery model market share analysis, 2019 & 2027
Fig. 40 Corporate wellness delivery model market: Segment dashboard
Fig. 41 Onsite market, 2016 - 2027 (USD Million)
Fig. 42 Offsite market, 2016 - 2027 (USD Million)
Fig. 43 Corporate wellness regional market share analysis, 2019 & 2027
Fig. 44 Corporate wellness regional market: Segment dashboard
Fig. 45 Regional market place: Key takeaways
Fig. 46 North America corporate wellness market, 2016 - 2027 (USD Million)
Fig. 47 U.S. corporate wellness market, 2016 - 2027 (USD Million)
Fig. 48 Canada corporate wellness market, 2016 - 2027 (USD Million)
Fig. 49 Europe corporate wellness market, 2016 - 2027 (USD Million)
Fig. 50 U.K. corporate wellness market, 2016 - 2027 (USD Million)
Fig. 51 Germany corporate wellness market, 2016 - 2027 (USD Million)
Fig. 52 France corporate wellness market, 2016 - 2027 (USD Million)
Fig. 53 Italy corporate wellness market, 2016 - 2027 (USD Million)
Fig. 54 Spain corporate wellness market, 2016 - 2027 (USD Million)
Fig. 55 Asia Pacific corporate wellness market, 2016 - 2027 (USD Million)
Fig. 56 Japan corporate wellness market, 2016 - 2027 (USD Million)
Fig. 57 China corporate wellness market, 2016 - 2027 (USD Million)
Fig. 58 India corporate wellness market, 2016 - 2027 (USD Million)
Fig. 59 Australia corporate wellness market, 2016 - 2027 (USD Million)
Fig. 60 Latin America corporate wellness market, 2016 - 2027 (USD Million)
Fig. 61 Brazil corporate wellness market, 2016 - 2027 (USD Million)
Fig. 62 Mexico corporate wellness market, 2016 - 2027 (USD Million)
Fig. 63 MEA corporate wellness market, 2016 - 2027 (USD Million)
Fig. 64 South Africa corporate wellness market, 2016 - 2027 (USD Million)
Fig. 65 Strategy framework
Fig. 66 Corporate wellness competitive landscape: Market position analysis (based on products, regional presence, and recent updates (2019))

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[臨床検査の世界市場:種類別(CBC、HGB / HCT、BMP、BUNクレアチニン、電解質テスト、HbA1c、CMP、肝臓パネル、腎臓パネル、脂質パネル)、最終用途別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆